NCT00926692

Brief Summary

The aim of this research is to define the human equivalent of mouse B1 cells.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
249

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2009

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2009

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

June 19, 2009

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 23, 2009

Completed
5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2014

Completed
Last Updated

August 26, 2015

Status Verified

August 1, 2015

Enrollment Period

5.3 years

First QC Date

June 19, 2009

Last Update Submit

August 24, 2015

Conditions

Healthy

Keywords

B-cellsCD5+B1 CellsHealthy Controls

Outcome Measures

Primary Outcomes (1)

  • Presence of B-1 cells in humans

    an equivalent cell type was isolated in humans

    determined over the years study in effect

Study Arms (1)

Healthy Subjects

All subjects are considered healthy

Other: Blood draw

Interventions

Blood drawOTHER

Subject will have blood draw.

Healthy Subjects

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Healthy Control Population

You may qualify if:

  • Subject is considered by the physician to be a healthy adult.

You may not qualify if:

  • Subject is under the age of 18
  • Subject has an infection or is currently ill

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Feinstein Institute for Medical Research

Manhasset, New York, 11030, United States

Location

MeSH Terms

Interventions

Blood Specimen Collection

Intervention Hierarchy (Ancestors)

Specimen HandlingClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisPuncturesSurgical Procedures, OperativeInvestigative Techniques

Study Officials

  • Daniel Griffin, M.D.

    Feinstein Institute for Medical Research

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Fellow Infectious Diseases

Study Record Dates

First Submitted

June 19, 2009

First Posted

June 23, 2009

Study Start

April 1, 2009

Primary Completion

July 1, 2014

Study Completion

July 1, 2014

Last Updated

August 26, 2015

Record last verified: 2015-08

Locations

US(1)